Quarterly report pursuant to Section 13 or 15(d)

Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)

v3.21.1
Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Prepaid Expense And Other Assets Current [Abstract]    
Refundable FDA filing fee   $ 2,876
Short-term deposits $ 2,267 2,360
Research and development tax credit receivable 672 801
Other prepaid assets 274 231
Prepaid insurance 253 415
Prepaid research and development expenses 95 157
Interest receivable 85  
Value added tax receivable 49 64
Total $ 3,695 $ 6,904